地址:武汉市洪山区光谷大道35号光谷总部国际时代 二期1栋1301
电话:18771149750
传真:18327026838
邮箱:sales@amyjet.com

艾美捷科技代理Monosan品牌。
MONOSAN公司,自1979年生产销售第一个抗大鼠T细胞单克隆抗体以来,一直为生命科学研究领域提供抗体和试剂。产品线包含单克隆抗体、多克隆抗体及试剂,产品系列包括:
(1)MONOSAN® Xtra系列
MONOSAN®Xtra常规MONOSAN®产品线的独特补充。MONOSAN® Xtra系列中的抗体特别适用于冷冻和FFPE组织切片的免疫组织化学(IHC)和免疫荧光(IF)研究。MONOSAN® Xtra单
克隆和多克隆抗体被证明具有优良的品质并显示出高一致性。
(2)MONOSAN®即用型系列
为了减少组织病理学工作流程并消除免疫染色中的不确定性,MONOSAN®设计了一种名为MONOSAN®即用型的预稀释抗体系。该系列包含用于冷冻和FFPE组织切片的免疫组织化学(IHC)
抗体产品。
(3)MONOSAN® 试剂系列
除了常规抗体产品外,MONOSAN®还提供MONOSAN®试剂。该产品线包含用于免疫组化目的的大量检测系统组合,如 MONOSAN® Plus(AP)聚合物试剂盒、MONOSAN® Plus (HRP)
广谱试剂盒和MONOSAN®(HRP)广谱试剂盒。MONOSAN®试剂检测试剂盒设计用于定性检测固定石蜡包埋组织切片、冷冻组织切片和细胞学样品中的抗原。
< " data-original="http://southernbiotech.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理Monosan品牌"> 艾美捷科技代理Monosan品牌
艾美捷科技代理Platypus Technologies品牌产品。
Platypus Technologies公司主要为生命科学领域提供:金属涂层基板、图案化基板和细胞迁移/侵袭检测解决方案。Platypus Technologies公司的产品在表面科学,金属涂层、细胞培养、
纳米技术、电化学以及化学和生物传感器方面都有应用。其愿景是通过应用表面科学为科学界开发工具和解决方案。产品包括:
(1)金属涂层基板:金属涂层基板经过精心设计,可确保在各种应用中的高性能,包括显微镜、光谱学和纳米技术研究。
(2)图案化基板:为先进的电子应用提供图案化电极,为研究者提供可靠性和精度保证。
(3)细胞迁移/侵袭检测:Oris平台由蛋白包被的96孔板组成,带有“塞子”屏障,可形成中央无细胞检测区,该平台用于研究细胞迁移或细胞侵袭。
< " data-original="http://southernbiotech.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理Platypus Technologies品牌产品。"> 艾美捷科技代理Platypus Technologies品牌产品。
艾美捷科技代理SynQuest品牌
SynQuest成立于1994年,专注于氟化有机和无机化学品,提供创造性和创新性的构建模块,试剂以及压缩和液化气体。
▍SynQuest公司的关键业务
● 电子材料: 高纯硅烷(99.9999%); 蚀刻气体NF₃/ClF₃(水分≤0.5 ppm);
● 分析科学:特色产品线包含 VOC检测标准品(EPA 8260系列); POPs持久污染物标样(符合斯德哥尔摩公约)。技术亮点:-86℃深冷存储保证稳定性;
● 定制合成:氘代化合物(D>99.5%);手性化合物(ee值>99.9%),可克级至吨级柔性生产。

▍SynQuest公司的主要产品
● 超高纯度化学品(纯度≥99.999%)
● 环境分析标准品(EPA/SOT合规)
● 半导体材料(光刻胶前驱体/蚀刻气体)
● 同位素标记化合物(¹³C/¹⁵N/²H标记率>99%)
▍SynQuest部分产品列表
| 品名 | 货号 | CAS号 | 分子量 | 分子式 | 纯度 | 规格 |
| 1,1,2,2-Tetrafluoroethane | 1100-3-10 | 359-35-3 | 102.032 | C2H2F4 | 98% | 5 g;25 g;Bulk |
| 1,1,1,2,3,3-Hexafluoropropane | 1100-3-27 | 431-63-0 | 152.039 | C3H2F6 | 98% | 100 g;250g;Bulk |
| 1,2,2,3-Tetrachloropropane | 1100-5-23 | 13116-53-5 | 181.87 | C3H4Cl4 | 99% | 5 g;25 g;Bulk |
| 1,2-Dichlorohexafluoropropane | 1100-6-19 | 661-97-2 | 220.92 | C3Cl2F6 | 100% | 5 g;25 g;Bulk |
| 1,2,3-Trichloropentafluoropropane | 1100-6-22 | 76-17-5 | 237.38 | C3Cl3F5 | 99% | 5 g;25 g;Bulk |
| 1,1-Dichloro-1-fluoroethane | 1100-7-21 | 1717-00-6 | 116.94 | C2H3Cl2F | 98% | 100 g;250g;Bulk |
| 3-Chloro-1,1,1-trifluoropropane | 1100-7-29 | 460-35-5 | 132.51 | C3H4ClF3 | 98% | 100 g;Bulk |
| 1-Bromoperfluorononane | 1100-A-16 | 558-96-3 | 548.973 | C9BrF19 | 98% | 5 g;25 g;Bulk |
| 1,2-Dibromo-3-fluoropropane | 1100-B-28 | 453-00-9 | 219.879 | C3H5Br2F | 98% | 1 g;5 g;Bulk |
| 1,2-Dibromo-2,3-dichloropropane | 1100-D-23 | 70289-31-5 | 270.77 | C3H4Br2Cl2 | 98% | 5 g;25 g;Bulk |
| 1,2-Dibromo-1-chlorotrifluoroethane | 1100-E-04 | 354-51-8 | 276.28 | C2Br2ClF3 | 98% | 100 g;Bulk |
| 1-Iodoperfluorodecane | 1100-J-17 | 423-62-1 | 645.981 | C10F21I | 98% | 25 g;100 g;Bulk |
| 1-Iodoperfluoropentane | 1100-J-51 | 638-79-9 | 395.942 | C5F11I | 98% | 5g;25 g;Bulk |
| Cyclopropane | 1200-1-03 | 75-19-4 | 42.081 | C3H6 | 99% | 5 g;25 g;Bulk |
| (E)-1,1,1,3-Tetrafluoro-2-butene | 1300-3-46 | 791616-87-0 | 128.07 | C4H4F4 | 98% | 5 g;25 g;Bulk |
| (Z)-1,1,1,3-Tetrafluoro-2-butene | 1300-3-47 | 791616-88-1 | 128.07 | C4H4F4 | 98% | 5 g;25 g;Bulk |
| 2,3-Dichloroprop-1-ene | 1300-5-15 | 78-88-6 | 110.97 | C3H4Cl2 | 98% | 100 g;250g;Bulk |
| 2,3-Dichlorohexafluorobutene-2 | 1300-6-08 | 303-04-8 | 232.93 | C4Cl2F6 | 98% | 25 g;100 g;Bulk |
| Bromotrifluoroethylene, inhibited | 1300-A-01 | 598-73-2 | 160.921 | C2BrF3 | 98% | 5 g;25 g;Bulk |
| 2-Bromo-1,1-difluoroethylene | 1300-B-01 | 359-08-0 | 142.931 | C2HBrF2 | 98% | 5 g;25 g;100g;Bulk |
| Hexafluoro-2-butyne | 1500-2-02 | 692-50-2 | 162.034 | C4F6 | 98% | 5 g;25 g;100g;Bulk |
| 3,3,3-Trifluoropropyne | 1500-3-02 | 661-54-1 | 94.036 | C3HF3 | 98% | 5 g;25 g;Bulk |
<艾美捷科技代理Tropic Marin品牌全系列产品
Tropic Marin公司于1964年在德国威斯巴登创立,凭借其丰富的海盐、矿物质混合物、细菌添加剂、测试套件和过滤设备产品线,Tropic Marin®为全球50多个国家的初学者、经验丰富的水族爱好者、动物园、大型水族馆、大学和实验室提供产品。

▎Tropic Marin产品线
●海盐系列
①PRO-REEF 珊瑚盐:高钙镁配方,促进硬骨珊瑚生长,稳定pH值,适用礁岩生态缸。
②BIO-ACTIF 活菌盐:添加天然生物聚合物与益生菌,增强生物抗病力,优化微生物平衡。
③经典海盐:含天然海水70种微量元素,医药级纯度,无硝酸盐/磷酸盐残留。
④溶解性:实验室验证的高溶解度,调配后比重精准匹配天然海水(1.024–1.026)。
●补充剂与养护产品
①TRACE-TRACE B 元素:针对珊瑚显色与健康的微量元素补充剂。
②NP-BACTO 系列:包含平衡剂(Balance)和生物滤材(Tricks),通过益生菌降解硝酸盐/磷酸盐,维护水质6。
③PRO-CORAL专业线:涵盖钙添加剂(BIO-CALCIUM)、碘补充剂(IODINE)及浮游生物粮(ZOOTON/PHYTON)。
▎Tropic Marin产品列表
| 品名 | 规格 | 货号 |
| A- Elements | 200 ml ;500 ml ;1000 ml | 24104 ;24123;24113 |
| All-For-Reef | 250 ml ;500 ml ;1000 ml;800g ;1600g | 26702 ; 26704 ;26706 ;26752;26754 |
| Amino-Organic | 250 ml | 25104 |
| Bio-Actif 海盐 | 4 kg;10 kg;12.5 kg;20 kg;25kg | 10304;10310;10312;10320;10325 |
| Bio-Actif Reactor 5000 | 5 L | 53105 |
| Bio-Magnesium | 450 g;1500 g;1000 ml | 29402;29432;29454 |
| Bio-Strontium | 200 g | 29002 |
| Block Iodine | 1000 ml | 28890 |
| Block Molydbenum | 1000 ml | 28892 |
| Block Nickel | 1000 ml | 28894 |
| Block Strontium | 1000 ml | 28896 |
| Block Zinc | 1000 ml | 28898 |
| Barium | 250 ml | 28830 |
| Boron | 500 ml | 28860 |
| Bromine | 500 ml | 28862 |
| Calcium | 500 ml | 28864 |
| Carbonate | 500 ml | 28866 |
| Chromium | 250 ml | 28832 |
| Cobalt | 250 ml | 28834 |
| Copper | 250 ml | 28836 |
| Fluorine | 500 ml | 28868 |
| Iodine | 250 ml | 28838 |
| Iron | 250 ml | 28840 |
| Lithium | 250 ml | 28842 |
| Magnesium | 500 ml | 28870 |
| Manganese | 250 ml | 28844 |
| Molybdenum | 250 ml | 28846 |
| Nickel | 250 ml | 28848 |
| Nitrogen | 500 ml | 28872 |
| Phosphate | 500 ml | 28874 |
| Potassium | 500 ml | 28876;24005 |
| Rubidium | 250 ml | 28850 |
| Selenium | 250 ml | 28852 |
| Strontium | 500 ml | 28878 |
| Sulfur | 500 ml | 28880 |
| Vanadium | 250 ml | 28854 |
| Tinc | 250 ml | 28854 |
| Carbo-Calcium | 500 ml;1000 ml;700 g;1400 g | 26202;26204;26252;26254 |
| Carbon | 400 g | 25604 |
| Ca / Mg Pro | Ca/Mg-Test Professional;Refill Pack | 28380;28790 |
| Classic 海盐 | 2 kg;4 kg;10 kg;12.5 kg;20 kg;25 kg | 10112 ;10124;10128;10130;10132;10130 |
| Compact Lab | Compact Lab | 28500 |
| Coral Clean | 250 ml | 24332 |
| Cyo-Control | 500 ml | 24354 |
| Elimi-Phos Rapid | 500 ml | 25354 |
| Elimi-NP | 50 ml;250 ml | 24422;24424 |
| Immuvit | 60 g | 24822 |
| Elimi-Phos | 100 g;200 g;400 g;1,5 kg | 25404;25414、25304;25424;25314 |
| K+ Elements | 200 ml ;500 ml ;1000 ml | 24204;24223;24213 |
| Fiji Meerwasser | 20升 | 10020 |
| KH Pro Test | KH-Test | 28784 |
| lod | 50 ml | 24304 |
| KH Test | KH-Test ;Refill Pack | 28240;28776 |
| K+ Pro Test | K+ Test Professional ;Refill Pack | 28390;28792 |
| Lipo-Garlic | 50 ml | 24812 |
| Liquid Buffer | 500 ml;1000 ml | 27062;27064 |
| Nitribiotic | 25 ml ;50 ml | 27202;27204 |
| Lipovit | 50 ml | 24802 |
| NO2/NO3 | NO2/NO3-Test;Refill Pack | 28260 ;28780 |
| NH4+/NHs Test | NH4+/NH3-Test;Refill Pack | 28270;28782 |
| NP-Bacto-Pellets | 500 ml ;1000 ml | 25702;25706 |
| NO2/ NO3 Pro Test | NO2/NO3-Test Professional;Refill Pack | 28360;28788 |
| NP-Bacto-Tricks | 2000 ml;5000 ml;10000 ml | 25724;25726;25728 |
| NP-Bacto-Balance | 500 ml;1000 ml | 24403;24405 |
| O-Megavital CBD | 60 g | 24862 |
| O-Megavital Nori | 17 g | 24871 |
| Original Balling Components | 1 kg;3 x 1 kg | A:26522;B:26524;C :26526;Set ABC:26528 |
| pH test | pH-Test saltwater;Refill Pack saltwater ;pH-Test freshwater ;Refill Pack freshwater | 28210;28770;28220;28772 |
| Phos-Start | 75 g | 24462 |
| Phos-Feed | 300 g | 24474 |
| Phyton | 60 g | 24622 |
| Phytonic | 50 ml;250 ml | 24652;24654 |
| Plus NP | 250 ml | 24454 |
| PO4 Pro | PO4-Test Professional;Refill Pack | 28350 ;28786 |
| PO4 Test | PO4-Test;Refill Pack | 28250 ;28778 |
| Potassium | 500 ml | 28876;24005 |
| Pro-Coral Mineral | 250 g | 25002 |
| Pro-Reef | 2 kg;4 kg;10 kg;12.5 kg;20 kg;25 kg | 10522;10524;10551;10560;10572;10581 |
| Pro-Tect | 1000 ml | 24094 |
| Professional Lab | Compact Lab | 28500 |
| Reef Actif | 60 g | 24702 |
| Reef Snow | 60 g | 24722 |
| Syn-Biotic | 4 kg;10 kg;12.5 kg;20 kg;25kg | 10404;10410;10412;10420;10425 |
| Triple Buffer | 250 g;1800 g | 27002;27052 |
| Zooton | 60 g | 24602 |
| Zootonic | 50 ml;250 ml | 24632 ;24634 |

Neuromab是一家由NIH资助成立的单克隆抗体库。
The UC Davis/NIH NeuroMab Facility is a national monoclonal antibody-generating resource funded by the National Institutes of Health (NIH). The mission of the UC Davis/NIH NeuroMab Facility is to provide a unique neuroscience-based approach to generating mouse monoclonal antibodies optimized for use in mammalian brain (NeuroMabs). NeuroMabs are generated from mice immunized with synthetic and recombinant immunogens corresponding to components of the neuronal proteome as predicted from genomic and other large-scale cloning efforts. Comprehensive biochemical and immunohistochemical analyses of human, primate and non-primate mammalian brain are incorporated into the UC Davis/NIH NeuroMab Facility screening procedure. This yields a subset of mouse mAbs that are optimized for use in brain (i.e., NeuroMabs): for immunohistochemical- based imaging studies of protein localization in adult, developing and pathological brain samples, for biochemical analyses of subunit composition and post-translational modifications of native brain proteins, and for proteomic analyses of native brain protein networks.
Neuromab的主要产品包括:
Array Tomography
Model Organisms
Disease Targets
产品列表:
| 抗体名称 |
| Anti-5-formylcytidine, NeuroMab clone N358/68 |
| Anti-5-hydroxymethylcytidine, NeuroMab clone N297/59 |
| Anti-6xHis, NeuroMab clone N144/14 |
| Anti-ADAM11, NeuroMab clone N441/35 |
| Anti-ADAM22-cytoplasmic, NeuroMab clone N46/30 |
| Anti-ADAM22-extracellular, NeuroMab clone N57/2 |
| Anti-AGPS neo-epitope, NeuroMab clone N444/63 |
| Anti-Aldh1L1 (Aldehyde dehydrogenase family 1 member L1), NeuroMab clone N103/39 |
| Anti-Aldh1L1 (Aldehyde dehydrogenase family 1 member L1), NeuroMab clone N103/31 |
| Anti-Alg13, NeuroMab clone N442/28 |
| Anti-Alpha-2C adrenergic receptor, NeuroMab clone N330A/80 |
| Anti-Alpha-2C adrenergic receptor, NeuroMab clone N330A/51 |
| Anti-AMIGO-1, NeuroMab clone L86/33 |
| Anti-AMIGO-1, NeuroMab clone L86/36 |
| Anti-AMIGO-1, NeuroMab clone L86A/37 |
| Anti-Ankyrin-B, NeuroMab clone N105/13 |
| Anti-Ankyrin-B, NeuroMab clone N105/17 |
| Anti-Ankyrin-G, NeuroMab clone N106/20 |
| Anti-Ankyrin-G, NeuroMab clone N106/36 |
| Anti-Ankyrin-G, NeuroMab clone N106/65 |
| Anti-Ankyrin-G, NeuroMab clone N106/43 |
| Anti-Ankyrin-R, NeuroMab clone N388A/10 |
| Anti-Ankyrin-R/G, NeuroMab clone N388A/27 |
| Anti-ANO3/TMEM16C, NeuroMab clone N454/91 |
| Anti-ANO5/TMEM16E, NeuroMab clone N421A/85 |
| Anti-ANO6/TMEM16F, NeuroMab clone N429/19 |
| Anti-ARHGAP4, NeuroMab clone N290B/25 |
| Anti-Arl13b, NeuroMab clone N295B/66 |
| Anti-Arx, NeuroMab clone N411/51 |
| Anti-ASIC1, NeuroMab clone N271/44 |
| Anti-ATAT1, NeuroMab clone N347/42 |
| Anti-Ataxin-1 11NQ, NeuroMab clone N76/8 |
| Anti-Ataxin-1 11NQ, NeuroMab clone N76/3 |
| Anti-Ataxin-1 wild-type, NeuroMab clone N65/37 |
| Anti-ATF4, NeuroMab clone N360A/24 |
| Anti-BAF53a, NeuroMab clone N336B/83 |
| Anti-BAF53b, NeuroMab clone N332B/15 |
| Anti-Bassoon, NeuroMab clone L124/59 |
| Anti-BBS3/Arl6, NeuroMab clone N302/10 |
| Anti-BBS5, NeuroMab clone N304B/115 |
| Anti-BDNF, NeuroMab clone N450/53 |
| Anti-Beta1-spectrin, NeuroMab clone N385/21 |
| Anti-Beta4-spectrin, NeuroMab clone N393/2 |
| Anti-Beta4-spectrin, NeuroMab clone N393/76 |
| Anti-BKBeta2 potassium channel subunit, NeuroMab clone N53/32 |
| Anti-BKBeta3a potassium channel subunit, NeuroMab clone N40B/18 |
| Anti-BKBeta4 potassium channel, NeuroMab clone L18A/3 |
| Anti-Botch1/Chac1, NeuroMab clone N116/14 |
| Anti-Bral1, NeuroMab clone N364/10 |
| Anti-Bral1, NeuroMab clone N364/42 |
| Anti-Brevican, NeuroMab clone N294A/6 |
| Anti-Brevican, NeuroMab clone N294A/10 |
| Anti-CALB1/calbindin, NeuroMab clone L109/39 |
| Anti-CALB1/calbindin, NeuroMab clone L109/57 |
| Anti-CALB2/calretinin, NeuroMab clone L122/6 |
| Anti-CALB2/calretinin, NeuroMab clone L122/68 |
| Anti-CASK scaffolding protein, NeuroMab clone K56A/50 |
| Anti-Caspr/paranodin/neurexin IV, NeuroMab clone K65/35 |
| Anti-Caspr2/paranodin, NeuroMab clone K67/25 |
| Anti-Cav1.2 calcium channel, NeuroMab clone L57/46 |
| Anti-Cav1.2, NeuroMab clone N263/31 |
| Anti-Cav1.3 calcium channel, NeuroMab clone L48A/9 |
| Anti-Cav1.3 calcium channel, NeuroMab clone N38/8 |
| Anti-Cav3.1 Ca2+ channel, NeuroMab clone N178A/9 |
| Anti-Cav3.2 calcium channel, NeuroMab clone N55/10 |
| Anti-Cav1 calcium channel, NeuroMab clone N7/18 |
| Anti-Cav尾2 calcium channel subunit, NeuroMab clone N8b/1 |
| Anti-Cav3 calcium channel, NeuroMab clone N473/36 |
| Anti-Cav尾4 calcium channel, NeuroMab clone N10/7 |
| Anti-Cdkl5, NeuroMab clone EA7 |
| Anti-CDY1/2, NeuroMab clone N143/38 |
| Anti-CDY1/2/L1/L2, NeuroMab clone N143/36 |
| Anti-Celf4/Brunol4, NeuroMab clone N446/80 |
| Anti-FOS, NeuroMab clone N486/32 |
| Anti-FOS, NeuroMab clone N486/76 |
| Anti-Clcn3, NeuroMab clone N258/5 |
| Anti-Clcn4, NeuroMab clone N222/6 |
| Anti-Clcn5, NeuroMab clone N406/47 |
| Anti-CLN3, NeuroMab clone N380/87 |
| Anti-CLN6, NeuroMab clone N400/24 |
| Anti-CNGA1/3 cyclic nucleotide-gated channel, NeuroMab clone L36/12 |
| Anti-Collybistin, NeuroMab clone L120/12 |
| Anti-Collybistin, NeuroMab clone L120/30 |
| Anti-Contactin/F3 scaffold protein, NeuroMab clone K73/20 |
| Anti-Copper-transporting ATPase 1, NeuroMab clone L60/4 |
| Anti-Copper-transporting ATPase 2 (Copper pump 2, Wilsons disease-associated protein, NeuroMab clone L62/29 |
| Anti-Co-Rest/RCOR1 Transcriptional Co-Repressor, NeuroMab clone K72/8 |
| Anti-DEPDC5, NeuroMab clone N463/52 |
| Anti-Dicer, NeuroMab clone N167/7 |
| Anti-DLX1 transcription factor, NeuroMab clone L43/40 |
| Anti-DNAH1, NeuroMab clone N251/14 |
| Anti-DNAH7, NeuroMab clone N250/21 |
| Anti-DNAIC1, NeuroMab clone UNC 65.56.18.11 |
| Anti-DNMT3L, NeuroMab clone N117/9 |
| Anti-Doc2b, NeuroMab clone N150/21 |
| Anti-Dopamine D2 receptor, NeuroMab clone N186/29 |
| Anti-Dopamine D3 receptor, NeuroMab clone N331/19 |
| Anti-EAAC1, NeuroMab clone N420/24 |
| Anti-FGF11 (Fibroblast growth factor 11), NeuroMab clone N92/14 |
| Anti-FGF12/FHF1, NeuroMab clone N94/17 |
| Anti-FGF13 (Fibroblast growth factor 13), NeuroMab clone N91/27 |
| Anti-FGF13B/FHF2B, NeuroMab clone N225A/10 |
| Anti-FGF14/FHF4, NeuroMab clone N56/21 |
| Anti-Fig4/Sac3, NeuroMab clone N202/7 |
| Anti-Flrt3, NeuroMab clone N353/13 |
| Anti-Foxi2, NeuroMab clone N349/96 |
| Anti-Foxi3, NeuroMab clone N359/28 |
| Anti-Frataxin, NeuroMab clone N191/7 |
| Anti-GABA-A-R-Alpha1, NeuroMab clone N95/35 |
| Anti-GABA-A-R-Alpha2, NeuroMab clone N399/19 |
| Anti-GABA-A-R-Alpha4, NeuroMab clone N398A/34 |
| Anti-GABA-A-R-Alpha5, NeuroMab clone N415/24 |
| Anti-GABA-A-R-Alpha6, NeuroMab clone N229A/32 |
| Anti-GABA-A-R-Beta1, NeuroMab clone N96/55 |
| Anti-GABA-A-R-Beta2/3, NeuroMab clone 62-3G1 |
| Anti-GABA-A-R-Beta3, NeuroMab clone N87/25 |
| Anti-Delta GABA-A receptor, NeuroMab clone N151/3 |
| Anti-GABA-A-R-Epsilon, NeuroMab clone N413/67 |
| Anti-GABA-A-R-Gamma2L, NeuroMab clone N452/69 |
| Anti-GABA-A-R-Gamma2L/S, NeuroMab clone N452/73 |
| Anti-GABA-A-R-Gamma2L/S, NeuroMab clone N452/30 |
| Anti-GABA-A-R-Pi, NeuroMab clone N431/64 |
| Anti- GABA-A-R-Theta, NeuroMab clone L123/109 |
| Anti-GABABR1 GABA-B receptor, NeuroMab clone N93A/49 |
| Anti-GABABR2 GABA-B receptor, NeuroMab clone N81/2 |
| Anti-GABABR2 GABA-B receptor, NeuroMab clone N81/37 |
| Anti-GAD65/67, NeuroMab clone L127/12 |
| Anti-GAD67, NeuroMab clone L127/8 |
| Anti-Gamma-protocadherin-A3, NeuroMab clone N144/17 |
| Anti-Gamma-protocadherin-B2, NeuroMab clone N148/30 |
| Anti-Gamma-protocadherin-C3, NeuroMab clone N174B/27 |
| Anti-Gamma-protocadherin-C4, NeuroMab clone N193A/13 |
| Anti-Gephyrin, NeuroMab clone L106/83 |
| Anti-Gephyrin, NeuroMab clone L106/93 |
| Anti-Gephyrin, NeuroMab clone L106/4 |
| Anti-GFAP, NeuroMab clone N206A/8 |
| Anti-GFAP-R416WT, NeuroMab clone N206B/9 |
| Anti-GFP (Green fluorescent protein), NeuroMab clone N86/8 |
| Anti-GFP (Green fluorescent protein), NeuroMab clone N86/38 |
| Anti-GFP (green fluorescent protein), NeuroMab clone N86/20 |
| Anti-GFP (green fluorescent protein), NeuroMab clone N86/44 |
| Anti-GIT1 scaffold protein, NeuroMab clone N39B/8 |
| Anti-GIT2 scaffold protein, NeuroMab clone N83/48 |
| Anti-GluA1/GluR1 glutamate receptor, NeuroMab clone N355/1 |
| Anti-GluA2/GluR2 glutamate receptor, NeuroMab clone L21/32 |
| Anti-KA2 kainate receptor, NeuroMab clone N279B/27 |
| Anti-GluN1/NR1 glutamate receptor, NeuroMab clone N308/48 |
| Anti-NR2A glutamate receptor, NeuroMab clone N327A/38 |
| Anti-GluN2A/NR2A glutamate receptor, NeuroMab clone N327/95 |
| Anti-GluN2B/NR2B glutamate receptor, NeuroMab clone N59/20 |
| Anti-GluN2B/NR2B glutamate receptor, NeuroMab clone N59/36 |
| Anti-GluN2C/NR2C, NeuroMab clone N422/18 |
| Anti- GluN3A/NR3A, NeuroMab clone N416/40 |
| Anti-Glycine receptor Alpha3, NeuroMab clone N424/45 |
| Anti-Glycine receptor Alpha3L, NeuroMab clone N424/48 |
| Anti-GRK6A/B, NeuroMab clone N142/28 |
| Anti-Gs protein alpha subunit, NeuroMab clone N192/12 |
| Anti-GST (Glutathione S-transferase), NeuroMab clone N100/13 |
| Anti-Haspin/GSG2, NeuroMab clone N128A/2 |
| Anti-HCN1 cyclic nucleotide-gated channel, NeuroMab clone N70/28 |
| Anti-HCN2 cyclic nucleotide-gated channel, NeuroMab clone N71/37 |
| Anti-HCN3 cyclic nucleotide-gated channel, NeuroMab clone N141/28 |
| Anti-HCN4 cyclic nucleotide-gated channel, NeuroMab clone N114/10 |
| Anti-Histone H2A.Z/V, NeuroMab clone N310/21 |
| Anti-Histone H2A.Z acetyl-Lys4/7/11, NeuroMab clone N299/39 |
| Anti-Histone H3.3, NeuroMab clone N158/28 |
| Anti-Histone H3 acetyl-Lys56, NeuroMab clone N307/12 |
| Anti-Histone H3-dimethyl-Arg8, NeuroMab clone N293/50 |
| Anti-Histone H3 pThr11, NeuroMab clone N123/19 |
| Anti-Histone H3 pThr11, NeuroMab clone N123/48 |
| Anti-Histone H4-dimethyl-Arg3, NeuroMab clone N309A/21 |
| Anti-Homer1L, NeuroMab clone L113/27 |
| Anti-Homer1L, NeuroMab clone L113/13 |
| Anti-Homer1, NeuroMab clone L113/130 |
| Anti-ICK, NeuroMab clone N451/73 |
| Anti-Iduna/RNF146, NeuroMab clone N201/35 |
| Anti-INPP4b, NeuroMab clone N171/17 |
| Anti IP3 receptor type 1 NeuroMab clone L24/18 |
| Anti-IRSp53/BAIAP2, NeuroMab clone L117/1 |
| Anti-JIP-2/IB-2, NeuroMab clone N135/37 |
| Anti-JMJD2A, NeuroMab clone N154/32 |
| Anti-KCC2 transporter, NeuroMab clone N1/66 |
| Anti-KCC2 transporter, NeuroMab clone N1/12 |
| Anti-KChIP1 potassium channel, NeuroMab clone K55/7 |
| Anti-KChIP2 potassium channel subunit, NeuroMab clone K60/73 |
| Anti-KChIP3 potassium channel, NeuroMab clone K66/38 |
| Anti-KChIP4 K+ channel, NeuroMab clone N423/75 |
| Anti-KCNT1/Slo2.2/Slack K+ channel, NeuroMab clone N3/26 |
| Anti-KCNT2/Slo2.1/Slick sodium- and chloride-activated ATP sensitive potassium channel, NeuroMab clone N11/33 |
| Anti-KCNU1/Slo3 pH-sensitive maxi potassium channel, NeuroMab clone N2/16 |
| Anti-Keyhole limpet hemocyanin, NeuroMab clone N132A/12 |
| Anti-Kir2.1 potassium channel, NeuroMab clone N112B/14 |
| Anti-Kir2.2 potassium channel, NeuroMab clone N124B/38 |
| Anti-Kir2.3 potassium channel, NeuroMab clone N25/35 |
| Anti-Kir2.4 potassium channel, NeuroMab clone N465/11 |
| Anti-Kir3.3 potassium channel, NeuroMab clone N455/15 |
| Anti-Kir6.1 potassium channel, NeuroMab clone N366/60 |
| Anti-Kir6.2 potassium channel, NeuroMab clone N363/71 |
| Anti-Kirrel3 short and long, NeuroMab clone N321C/49 |
| Anti-Kirrel3 short isoform 3, NeuroMab clone N320/48 |
| Anti-Kv1.1 potassium channel subunit, NeuroMab clone K20/78 |
| Anti-Kv1.1 potassium channel (external), NeuroMab clone K36/15 |
| Anti-Kv1.2 potassium channel subunit, NeuroMab clone K14/16 |
| Anti-Kv1.2 potassium channel subunit, NeuroMab clone L76/36 |
| Anti-Kv1.3 potassium channel, NeuroMab clone L23/27 |
| Anti-Kv1.4 potassium channel subunit, NeuroMab clone K13/31 |
| Anti-Kv1.4 potassium channel (extracellular), NeuroMab clone L71/5 |
| Anti-Kv1.5 potassium channel, NeuroMab clone K7/45 |
| Anti-Kv1.6 potassium channel subunit, NeuroMab clone K19/36 |
| Anti-Kv1.7 potassium channel, NeuroMab clone N471/27 |
| Anti-Kv11.3 potassium channel, NeuroMab clone N447/24 |
| Anti-Kv2.1 potassium channel subunit, NeuroMab clone L83/11 |
| Anti-Kv2.1 potassium channel subunit, NeuroMab clone K89/34 |
| Anti-Kv2.1 potassium channel subunit, NeuroMab clone L80/21 |
| Anti-Kv2.1 potassium channel (external), NeuroMab clone K39/25 |
| Anti-Kv2.2 potassium channel, NeuroMab clone K37/89 |
| Anti-Kv2.2 potassium channel, NeuroMab clone N372C/51 |
| Anti-Kv2.2 potassium channel, NeuroMab clone N372B/60 |
| Anti-Kv2.2 potassium channel, NeuroMab clone N372B/1 |
| Anti-Kv3.1b potassium channel, NeuroMab clone N16b/8 |
| Anti-Kv3.2 potassium channel, NeuroMab clone N410/17 |
| Anti-Kv3.3 potassium channel, NeuroMab clone N375/67 |
| Anti-Kv3.4 potassium channel, NeuroMab clone N72/16 |
| Anti-Kv4.2 potassium channel subunit, NeuroMab clone L28/4 |
| Anti-Kv4.2 potassium channel (external), NeuroMab clone K57/1 |
| Anti-Kv4.3 potassium channel subunit, NeuroMab clone K75/41 |
| Anti-Kv4.3 potassium channel subunit, NeuroMab clone K75/30 |
| Anti-Kv6.1 potassium channel, NeuroMab clone N474/27 |
| Anti-Kv6.4 potassium channel, NeuroMab clone N458/10 |
| Anti-KCNQ1 potassium channel, NeuroMab clone N37A/10 |
| Anti-KCNQ2 potassium channel, NeuroMab clone N26A/23 |
| Anti-KCNQ4 potassium channel, NeuroMab clone N43/6 |
| Anti-Kv8.2 potassium channel, NeuroMab clone N448/88 |
| Anti-Kv8.2 potassium channel, NeuroMab clone N448/50 |
| Anti-Kv9.1 potassium channel, NeuroMab clone N461/19 |
| Anti-Kv9.2 potassium channel, NeuroMab clone N460/19 |
| Anti-Kvβ1.1 potassium channel subunit, NeuroMab clone K9/40 |
| Anti-Kv1.2 potassium channel subunit, NeuroMab clone K47/42 |
| Anti-Kv尾2 potassium channel, NeuroMab clone K17/70 |
| Anti-Laforin, NeuroMab clone N84/37 |
| Anti-LAR/PTPRF, NeuroMab clone N165/38 |
| Anti-Lgi1, NeuroMab clone N283/7 |
| Anti-Lhx6.1, NeuroMab clone N228A/16 |
| Anti-LRP4 (cytoplasmic), NeuroMab clone N164/6 |
| Anti-LRP4 (extracellular), NeuroMab clone N207/27 |
| Anti-LRRK1, NeuroMab clone N341/37 |
| Anti-LRRK1, NeuroMab clone N341/12 |
| Anti-LRRK2/Dardarin, NeuroMab clone N241A/34 |
| Anti-LRRK2/Dardarin, NeuroMab clone N231B/34 |
| Anti-LRRK2/Dardarin, NeuroMab clone 8G10 |
| Anti-LRRK2/Dardarin, NeuroMab clone N138/6 |
| Anti-LRRK2/Dardarin-pSer910, NeuroMab clone 1D8 |
| Anti-LRRTM2, NeuroMab clone N209C/35 |
| Anti-LRRTM4, NeuroMab clone N205B/22 |
| Anti-Mad3, NeuroMab clone N129A/6 |
| Anti-Mad3, NeuroMab clone N129/15 |
| Anti-Malin, NeuroMab clone N85/18 |
| Anti-MBP (Maltose-binding protein), NeuroMab clone N128A/4 |
| Anti-MAP3K12, NeuroMab clone N377/20 |
| Anti-MAP3K12, NeuroMab clone N377/83 |
| Anti-MECP2, NeuroMab clone N227/21 |
| Anti-MESD, NeuroMab clone N88/12 |
| Anti-MFF, NeuroMab clone N382/14 |
| Anti-MFF (exon 1), NeuroMab clone N382/69 |
| Anti-MGL, NeuroMab clone N90/20 |
| Anti-mGluR1/5 (group I) glutamate receptor, NeuroMab clone N75/3 |
| Anti- mGluR1/5 (group I) glutamate receptor, NeuroMab clone N75/33 |
| Anti-Miro2, NeuroMab clone N384/63 |
| Anti-MiRP4 potassium channel, NeuroMab clone N472/88 |
| Anti-Mitofusin-1 (Mfn1), NeuroMab clone N111/24 |
| Anti-Mitofusin-2 (Mfn2), NeuroMab clone N153/5 |
| Anti-MMACHC, NeuroMab clone N230/21 |
| Anti-MMP9 metalloproteinase, NeuroMab clone L51/82 |
| Anti-MOG, NeuroMab clone L94/54 |
| Anti-Mortalin/GRP75, NeuroMab clone N52A/42 |
| Anti-MPP8, NeuroMab clone N119/44 |
| Anti-NALCN, NeuroMab clone N185/7 |
| Anti-Nav1.1 sodium channel, NeuroMab clone K74/71 |
| Anti-Nav1.2 sodium channel, NeuroMab clone K69/3 |
| Anti-Nav1.4 sodium channel, NeuroMab clone N255/38 |
| Anti-Nav1.5 sodium channel, NeuroMab clone N397/19 |
| Anti-Nav1.6 sodium channel, NeuroMab clone K87A/10 |
| Anti-Nav1.7 sodium channel, NeuroMab clone N68/6 |
| Anti-Nav1.8 sodium channel, NeuroMab clone N134/12 |
| Anti-Navbeta1 Na+ channel, NeuroMab clone N405/74 |
| Anti-Navbeta2 Na+ channel, NeuroMab clone N395/68 |
| Anti-Navbeta3 Na+ channel, NeuroMab clone N396/29 |
| Anti-Navbeta4 sodium channel, NeuroMab clone N168/6 |
| Anti-NCKX4, NeuroMab clone N414/25 |
| Anti-Neuregulin-CRD (Cysteine-rich domain, Type III), NeuroMab clone N126B/31 |
| Anti-Neuregulin-HBD (Heparin-binding domain, Type I/II), NeuroMab clone N120A/9 |
| Anti-Neurexin-1-Beta, NeuroMab clone N170A/1 |
| Anti-Neurexin-1-Beta, NeuroMab clone N170A/26 |
| Anti-Neuroligin-1, NeuroMab clone N97A/31 |
| Anti-Neuroligin-2, NeuroMab clone L107/39 |
| Anti-Neuroligin-3, NeuroMab clone N110/29 |
| Anti-Neuroligin-4*, NeuroMab clone N98/47 |
| Anti-Neuroligin-4*, NeuroMab clone N98/7 |
| Anti-NGL-1 (Netrin-G1 ligand), NeuroMab clone N49A/21 |
| Anti-NGL-2 (Netrin-G2 ligand) NeuroMab clone N50/36 |
| Anti-NGL-3 (Netrin-G3 ligand), NeuroMab clone N51/6 |
| Anti-NKCC1, NeuroMab clone N161/20 |
| Anti-NOS1/nNOS, NeuroMab clone L121/25 |
| Anti-NOS1/nNOS, NeuroMab clone L121/42 |
| Anti-Notch1, NeuroMab clone N253/32 |
| Anti-Npas4, NeuroMab clone N408/62 |
| Anti-Npas4, NeuroMab clone N408/79 |
| Anti-Neuropeptide Y, NeuroMab clone L115/13 |
| Anti-NPY2R, NeuroMab clone L119/106 |
| Anti-NrCAM, NeuroMab clone N343/26 |
| Anti-NSD1, NeuroMab clone N312/10 |
| Anti-NSD3, NeuroMab clone N348/82 |
| Anti-OCRL/INPP5b, NeuroMab clone N166A/26 |
| Anti-Olig1, NeuroMab clone N149/25 |
| Anti-Pan-Ankyrin, NeuroMab clone N388A/60 |
| Anti-Pancortin, NeuroMab clone K96/7 |
| Anti-Pan-FHF-A, NeuroMab clone N235/22 |
| Anti-Pan-Gamma-protocadherin-A, NeuroMab clone N144/32 |
| Anti-Pan-Gamma-protocadherin, NeuroMab clone N159/5 |
| Anti-Pan-GRK, NeuroMab clone N145/20 |
| Anti-Pan-KChIP potassium channel, NeuroMab clone K55/82 |
| Anti-Pan-Kv potassium channel, NeuroMab clone K40/17 |
| Anti-Pan-Kvbeta potassium channel, NeuroMab clone K25/73 |
| Anti-Pan-MAGUK scaffold proteins, NeuroMab clone K28/86 |
| Anti-Pan-Nav1 sodium channel, NeuroMab clone N419/40 |
| Anti-Pan-Nav1 sodium channel, NeuroMab clone N419/78 |
| Anti-pan-Neurofascin, NeuroMab clone L11A/41 |
| Anti-Pan-Neurofascin (external), NeuroMab clone A12/18 |
| Anti-Pannexin-2, NeuroMab clone N121A/1 |
| Anti-Pannexin-2, NeuroMab clone N121A/31 |
| Anti-Pan-PTPR, NeuroMab clone N165/43 |
| Anti-Pan-QKI, NeuroMab clone N147/6 |
| Anti-Pan-SAPAP, NeuroMab clone N127/31 |
| Anti-pan-Shank (SH3 and multiple ankyrin repeat domains protein) scaffold protein, NeuroMab clone N23B/49 |
| Anti-Pan-Synapsin, NeuroMab clone L125/129 |
| Anti-Pan-Thyroid hormone receptor, NeuroMab clone N403/63 |
| Anti-PARIS/ZNF746, NeuroMab clone N196/16 |
| Anti-Parvalbumin, NeuroMab clone L114/3 |
| Anti-Parvalbumin, NeuroMab clone L114/81 |
| Anti-PEX6, NeuroMab clone N233/8 |
| Anti-PEX7, NeuroMab clone N232/9 |
| Anti-Phosphoserine-2-OEt, NeuroMab clone N257/25 |
| Anti-Phosphoserine-2-OH, NeuroMab clone N259/48 |
| Anti-Phosphoserine-2-OMe, NeuroMab clone N262/16 |
| Anti-PhyH/PAHX, NeuroMab clone N210/5 |
| Anti-PICK1 scaffold, NeuroMab clone L20/8 |
| Anti-PINK1, NeuroMab clone N4/15 |
| Anti-PINK1, NeuroMab clone N4/49 |
| Anti-PINK1, NeuroMab clone N4/19 |
| Anti-PINK1, NeuroMab clone N357/6 |
| Anti-Proser1, NeuroMab clone N456/39 |
| Anti-Prrt2, NeuroMab clone N485/22 |
| Anti-PSD-93/Chapsyn-110 scaffold protein, NeuroMab clone N18/30 |
| Anti-PSD-93/Chapsyn-110 scaffold protein, NeuroMab clone N18/28 |
| Anti-PSD-95 MAGUK scaffold protein, NeuroMab clone K28/43 |
| Anti-PSD-95 MAGUK scaffold protein, NeuroMab clone K28/74 |
| Anti-QKI-5-NLS, NeuroMab clone N195A/16 |
| Anti-QKI-6, NeuroMab clone N182/17 |
| Anti-QKI-7, NeuroMab clone N183/15 |
| Anti-QKI-7b, NeuroMab clone N194/11 |
| Anti-RBM17/SPF45, NeuroMab clone N219/5 |
| Anti-REEP, NeuroMab clone N326D/13 |
| Anti-REEP1, NeuroMab clone N345/51 |
| Anti-REEP1/2, NeuroMab clone N326D/29 |
| Anti-REEP2, NeuroMab clone N326D/2 |
| Anti-Rem2, NeuroMab clone N324/2 |
| Anti-RGS14, NeuroMab clone N133/21 |
| Anti-RGS14, NeuroMab clone N133/35 |
| Anti-Rufy3, NeuroMab clone N483/84 |
| Anti-Rufy3, NeuroMab clone N483/126 |
| Anti-Rufy3, NeuroMab clone N483/26 |
| Anti-S100A5, NeuroMab clone N176A/35 |
| Anti-SALM2 synaptic adhesion-like molecule, NeuroMab clone N52B/27 |
| Anti-SALM5/LRFN5, NeuroMab clone N140A/12 |
| Anti-SAP102 MAGUK scaffold protein, NeuroMab clone N19/2 |
| Anti-SAP97 scaffold protein, NeuroMab clone K64/15 |
| Anti-SAPAP1, NeuroMab clone N238/29 |
| Anti-SAPAP1, NeuroMab clone N238/30 |
| Anti-SAPAP1/2, NeuroMab clone N238/31 |
| Anti-SAPAP2, NeuroMab clone N459/84 |
| Anti-SAPAP3, NeuroMab clone L126/93 |
| Anti-SCG10/stathmin-2, NeuroMab clone L5/1 |
| Anti-SH3GL1, NeuroMab clone K51/1 |
| Anti-Shank1/ SPANK-1/Synamon/SSTRIP scaffold protein, NeuroMab clone N22/21 |
| Anti-Shank1 and Shank3, NeuroMab clone N367/51 |
| Anti-Shank2/ProSAP1/Spank-3/CortBP1 scaffold protein,NeuroMab clone N23B/6 |
| Anti-Shank3 scaffold protein, NeuroMab clone N69/46 |
| Anti-Shank3, NeuroMab clone N367/62 |
| Anti-SK2 potassium channel, NeuroMab clone K78/29 |
| Anti-Slo1/BKAlpha potassium channel, NeuroMab clone L6/23 |
| Anti-Slo1/BKAlpha potassium channel, NeuroMab clone L6/48 |
| Anti-Slo1/BKAlpha potassium channel, NeuroMab clone L6/60 |
| Anti-Snapin (SNAP25 binding protein), NeuroMab clone L8/15 |
| Anti-SNAT1 Neurotransmitter Transporter NeuroMab clone N104/37 |
| Anti-SNAT1 Neurotransmitter Transporter NeuroMab clone N104/32 |
| Anti-SST/Somatostatin, NeuroMab clone L111/118 |
| Anti-S-tag, NeuroMab clone N56/9 |
| Anti-Stonin-2, NeuroMab clone N346/9 |
| Anti-SUR1, NeuroMab clone N289/16 |
| Anti-SUR1 and SUR2B, NeuroMab clone N323A/31 |
| Anti-SUR2A, NeuroMab clone N319A/14 |
| Anti-SUR2B, NeuroMab clone N323B/20 |
| Anti-SVOP, NeuroMab clone N356/9 |
| Anti-SVOP, NeuroMab clone N356/23 |
| Anti-Synapsin-III, NeuroMab clone L125/121 |
| Anti-Synaptotagmin-10, NeuroMab clone N269/73 |
| Anti-Synaptotagmin-12, NeuroMab clone N277/7 |
| Anti-Synaptotagmin-3, NeuroMab clone N278/19 |
| Anti-Synaptotagmin-5, NeuroMab clone N274/8 |
| Anti-Synaptotagmin-6, NeuroMab clone N270/47 |
| Anti-Synaptotagmin-7, NeuroMab clone N275/14 |
| Anti-Synaptotagmin-9, NeuroMab clone N276A/15 |
| Anti-SynCAM1 cell adhesion molecule, NeuroMab clone L45/30 |
| Anti-SynCAM4, NeuroMab clone N244/5 |
| Anti-SynDIG1/Tmem90b, NeuroMab clone L42/17 |
| Anti-SynDIG3/Tmem91, NeuroMab clone N160/21 |
| Anti-SynDIG4, NeuroMab clone L102/45 |
| Anti-Tafazzin, NeuroMab clone N173B/13 |
| Anti-TALK1 potassium channel, NeuroMab clone N466/14 |
| Anti-TARPGamma2/Stargazin, NeuroMab clone N245/1 |
| Anti-TARPGamma2/4/8, NeuroMab clone N245/36 |
| Anti-TASK1 potassium channel, NeuroMab clone N374/48 |
| Anti-Tauro-GM2, NeuroMab clone N175/9 |
| Anti-THAP1, NeuroMab clone N325B/65 |
| Anti-THIK-2 potassium channel, NeuroMab clone N468/37 |
| Anti-Thioredoxin, NeuroMab clone N245/44 |
| Anti-Thorase (Atad1), NeuroMab clone N125/10 |
| Anti-Thyroid hormone receptor beta1, NeuroMab clone N402/13 |
| Anti-Thyroid hormone receptor beta1, NeuroMab clone N402/46 |
| Anti- TRAAK potassium channel, NeuroMab clone N445/27 |
| Anti-TRAK1, NeuroMab clone N389/9 |
| Anti-TRAK2, NeuroMab clone N390/43 |
| Anti-TRESK potassium channel, NeuroMab clone N467/1 |
| Anti-TRIP8b (constant), NeuroMab clone N212/7 |
| Anti-TRIP8b (constant), NeuroMab clone N212/17 |
| Anti-TRIP8b (exon 1a/5 junction), NeuroMab clone N291C/22 |
| Anti-TRIP8b (exon 1b), NeuroMab clone N212A/34 |
| Anti-TRIP8b (exon 4), NeuroMab clone N212/3 |
| Anti-TrpC1 calcium channel, NeuroMab clone 1F1 |
| Anti-TrpC4 calcium channel, NeuroMab clone N77/15 |
| Anti-TrpC5 calcium channel, NeuroMab clone N67/15 |
| Anti-TrpC7 calcium channel, NeuroMab clone N64A/36 |
| Anti-TrpM4, NeuroMab clone L88/86 |
| Anti-TrpM6, NeuroMab clone N470/22 |
| Anti-TrpM7 ion channel and Ser/Thr kinase, NeuroMab clone N74/25 |
| Anti-TRPML3/Mucolipin-3, NeuroMab clone N268/19 |
| Anti-TrpV1, NeuroMab clone N221/17 |
| Anti-TrpV1, NeuroMab clone N221/12 |
| Anti-TrpV3 cation channel, NeuroMab clone N15/4 |
| Anti-TrpV3 cation channel, NeuroMab clone N15/39 |
| Anti-TWIK-2 potassium channel, NeuroMab clone N469/28 |
| Anti-Uncx, NeuroMab clone N155/9 |
| Anti-VAChT vesicular acetylcholine transporter, NeuroMab clone N6/38 |
| Anti-VAChT, NeuroMab clone N425/45 |
| Anti-VAPA, NeuroMab clone N479/12 |
| Anti-VAPA, NeuroMab clone N479/22 |
| Anti-VAPA/B, NeuroMab clone N479/107 |
| Anti-VDAC1, NeuroMab clone N152B/23 |
| Anti-Versican, NeuroMab clone N351/23 |
| Anti-Versican, NeuroMab clone N351/24 |
| Anti-VGAT, NeuroMab clone L118/80 |
| Anti-VGAT, NeuroMab clone L118/66 |
| Anti-VGlut1, NeuroMab clone N28/9 |
| Anti-VGlut2, NeuroMab clone N29/29 |
| Anti-VGlut3, NeuroMab clone N34/34 |
| Anti-VIP, NeuroMab clone L108/92 |
| Anti-VMAT1, NeuroMab clone N440/21 |
| Anti-VMAT1, NeuroMab clone N440/61 |
| Anti-Slc18a2/VMAT2, NeuroMab clone N449/73 |
| Anti-Zebrafish VSP/TPTE, NeuroMab clone N432/21 |
| Anti-Zebrafish VSP/TPTE, NeuroMab clone N432/63 |
| Anti-WAVE1/SCAR, NeuroMab clone K91/36 |
| Anti-WNK1, NeuroMab clone N391/68 |
| Anti-WRN, NeuroMab clone N428/12 |
| Zebrafish PSD Marker, NeuroMab clone N286/74 |
| Anti-Zinedin/Striatin-4, NeuroMab clone K88/64 |
| Anti-ZIP3, NeuroMab clone N476/9 |
| Anti-ZNF423, NeuroMab clone N328B/37 |
<艾美捷科技代理Vectorbiolabs品牌全系列产品
Vector Biolabs是一家专注于提供高质量AAV(腺相关病毒)和腺病毒产品的生物科技公司,总部位于宾夕法尼亚州费城。Vector Biolabs公司提供包括定制病毒载体生产、载体设计、克隆、扩增、包装、纯化和滴度测定在内的服务,并且拥有一个包含超过90,000种针对人类、小鼠和大鼠基因组定制的AAV产品目录,服务于包括生物制药公司和研究机构在内的全球客户。此外,Vector Biolabs 为研究界提供与基因表达、基因编辑和基因沉默相关的服务。

▍Vectorbiolabs公司的产品与服务
● AAV定制生产:根据客户需求,定制生产AAV载体,以满足特定的研究或治疗需求。
● AAV控制产品:提供一系列用于AAV基因治疗的控制产品,确保实验的准确性和可靠性。
● 腺病毒建设与扩增:提供腺病毒的构建和扩增服务,支持客户的病毒载体研究。
● shRNA筛选/验证与产品目录:提供shRNA筛选和验证服务,以及相关的产品目录,帮助客户进行基因沉默研究。
使用AAV进行基因治疗的好处:
①低免疫反应:AAV载体引发免疫反应的可能性较低,适合敏感应用。
②稳定的基因递送:提供非整合基因递送,降低诱变风险。
③可扩展的生产:确保从小规模到大规模的研究和临床试验的可靠供应。
④广泛的治疗应用:多功能性使其成为靶向大脑、肝脏和视网膜等器官的理想选择。
| 特性 | AAV | 腺病毒 (Adenovirus) |
| 基因表达 | 长期、稳定表达 | 快速、瞬时表达 |
| 免疫原性 | 低 | 高 |
| 装载容量 | ~4.7 kb | ~8 kb - 38 kb (大得多) |
| 趋向性/靶向能力 | 高 - 可通过不同衣壳定制 | 广泛,可靶向多种组织 |
| 最佳应用场景 | 体内研究,长期表达 | 体外 & 体内研究,癌症 & 疫苗研究 |
▍Vectorbiolabs部分产品列表
| 品名 | 货号 | AAV Serotype | AAV ITR | Promoter | Reporter | Storage Buffer | Titer | Viral Backbone | Volume (µL) |
| AAV1-LacZ | 7001 | AAV1 | AAV2 | CMV (ubiquitous) | LacZ | PBS/5% Glycerol | 1x10^13 GC/ml | Recombinant AAV | 20 |
| AAV1-GFP | 7002 | AAV1 | AAV2 | CMV (ubiquitous) | eGFP | PBS/5% Glycerol | 1x10^13 GC/ml | Recombinant AAV | 20 |
| AAV2-LacZ | 7003 | AAV2 | AAV2 | CMV (ubiquitous) | LacZ | PBS/5% Glycerol | 1x10^13 GC/ml | Recombinant AAV | 20 |
| AAV2-GFP | 7004 | AAV2 | AAV2 | CMV (ubiquitous) | eGFP | PBS/5% Glycerol | 1x10^13 GC/ml | Recombinant AAV | 20 |
| AAV5-LacZ | 7005 | AAV5 | AAV2 | CMV (ubiquitous) | LacZ | PBS/5% Glycerol | 1x10^13 GC/ml | Recombinant AAV | 20 |
| AAV5-GFP | 7006 | AAV5 | AAV2 | CMV (ubiquitous) | eGFP | PBS/5% Glycerol | 1x10^13 GC/ml | Recombinant AAV | 20 |
| AAV9-GFP | 7007 | AAV9 | AAV2 | CMV (ubiquitous) | eGFP | PBS/5% Glycerol | 1x10^13 GC/ml | Recombinant AAV | 20 |
| AAV6-GFP | 7008 | AAV6 | AAV2 | CMV (ubiquitous) | eGFP | PBS/5% Glycerol | 1x10^13 GC/ml | Recombinant AAV | 20 |
| AAV1-Cre | 7010 | AAV1 | AAV2 | CMV (ubiquitous) | - | PBS/5% Glycerol | 1x10^13 GC/ml | Recombinant AAV | 20 |
| AAV2-Cre | 7011 | AAV2 | AAV2 | CMV (ubiquitous) | - | PBS/5% Glycerol | 1x10^13 GC/ml | Recombinant AAV | 20 |
| AAV5-Cre | 7012 | AAV5 | AAV2 | CMV (ubiquitous) | - | PBS/5% Glycerol | 1x10^13 GC/ml | Recombinant AAV | 20 |
| AAV6-Cre | 7013 | AAV6 | AAV2 | CMV (ubiquitous) | - | PBS/5% Glycerol | 1x10^13 GC/ml | Recombinant AAV | 20 |

艾美捷科技特约代理ScienCell品牌。
ScienCell公司为研究界提供各种高质量的正常人类和动物细胞、细胞培养基和试剂、基因分析工具、细胞衍生的分子生物学产品、基于细胞的检测试剂盒和干细胞产品。
ScienCell公司产品线包括:
(1)原代细胞:采用ScienCell独有的方法从健康的人和动物组织中分离出来,在早期传代时进行冷冻保存,具有出色的细胞活力。
(2)细胞培养基:ScienCell的各种细胞培养基均为液体形式,包括特殊、经典和补充品种。每种产品均专为原代细胞的最佳营养和生长而设计。
(3)干细胞:干细胞是独特的细胞,具有在体内发育成各种特殊细胞类型的卓越能力,它们的特点是具有自我更新和分化成不同细胞谱系的能力。
(4)遗传学与基因组学:提供定制引物设计和试剂盒服务。
(5)分子生物学:产品:cDNA、基因组DNA、总RNA、MicroRNA、细胞裂解物和细胞沉淀。
(6)基于细胞的检测:ScienCell开发了多种基于细胞的检测检测试剂盒,包括新陈代谢、氧化应激和干细胞等许多领域,并提供酶活性、代谢物水平和细胞生长状态的定量结果。
(7)生长因子和蛋白质:ScienCell提供高质量生长因子、细胞因子和重组蛋白。
< " data-original="http://southernbiotech.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技特约代理ScienCell品牌"> 艾美捷科技特约代理ScienCell品牌
艾美捷科技代理G-Biosciences品牌。
G-Biosciences是一家专注于蛋白质组学研究的美国公司,产品广泛应用于学术研究和工业制造领域,包括:蛋白质检测、样品制备、电泳、蛋白质印迹、质谱、测定开发、抗体生产和蛋白质
纯化等。目前,G-Biosciences的高品质产品已经被超过25,000篇文章引用,并且这个数据还是不断增加。
G-Biosciences旨在提供试剂、特殊化学品、缓冲液、分析、应用试剂盒等各类研究工具;G-Biosciences还可以提供符合生物技术行业cGMP要求产品、高质量的定制和OEM制造。目前厂家
已经通过美国ISO9001:2015认证。
G-Biosciences公司产品包括:
(1)蛋白质组学:完整的蛋白质组学产品组合,包括蛋白质提取、分离和蛋白质色谱,到蛋白质标记和缀合和随后的蛋白质检测(蛋白质印迹和质谱)
(2)生物测定:用于测定开发和蛋白质检测的广泛的抗体、重组蛋白和ELISA库。细胞健康检测、SAM甲基转移酶、蛋白酶、磷酸酶和报告基因检测。
(3)DNA和RNA:大量基因组DNA和质粒DNA提取产品可供选择。RNA分离和净化试剂。经济实惠的PCR试剂,包括Taq和dNTPS。酵母DNA分离和转化试剂盒。
< " data-original="http://southernbiotech.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理G-Biosciences品牌"> 艾美捷科技代理G-Biosciences品牌
艾美捷科技代理DCN Dx品牌全系列产品
DCN Dx是一家专注于体外诊断(IVD)领域内快速即时诊断(POC)检测试剂的开发和制造的公司。快速免疫检测试剂的合约开发是DCN Dx所有业务的核心。Dcndx公司专注于侧向层析法(lateral flow)、穿流法(flow through)和微流控(microfluidic)技术平台,具有高灵敏度、定量检测、多重检测以及读数仪集成的高质量要求。DCNDx还提供多种产品和服务,以协助客户在开发的任何阶段:
● 定制的、私有的侧向层析技术教育培训课程: 在此课程中,将教授如何开发和制造快速检测试剂的细节;
● 咨询服务: 协助解决快速检测试剂开发、生产、法规注册和商业化过程中的任何问题;
● 定制化的蛋白-蛋白、蛋白-颗粒、小分子-蛋白和小分子-颗粒结合物;
● 侧向层析材料入门套件、结合物试剂盒、试剂、测试卡盒和材料: 用于快速检测试剂的开发过程。
▍DCN Dx产品列表
| 品名 | Weight | Dimensions | 产品描述 |
| Blood Collection/Separation Materials Kit | 5.5 LBS | 10 × 14 × 3.5 IN | 集血液采集与红细胞分离功能于一体的套装设备 |
| Nucleic Acid Lateral Flow Kit | 2 LBS | 14 × 12 × 4 IN | 兼容 DTT 的试剂盒检测标记的 DNA 扩增产物 |
| Basic Lateral Flow Training | - | - | 侧向层析技术能力提升 |
| MICA-200C LFA Cassettes | 1.5 LBS | 12.25 × 11 × 1.5 IN | 高性能侧向层析 (LFA)卡盒 |
| Lateral Flow Materials Kits | 16 LBS | 16 × 16 × 16 IN | 侧向层析材料套件 |
| Colloidal Gold | 2.5 LBS | 8.5 × 3.5 × 3.5 IN | DCNovations胶体金,提供大宗采购优惠价 |
| Cellulose NanoBeads | - | - | 采用 NanoAct™纤维素纳米珠,增强侧向层析检测性能 |
| CNB Conjugation Kit | 8 LBS | 16 × 16 × 16 IN | 为NanoAct™纤维素纳米珠提供可靠的偶联解决方案 |
| Colloidal Gold Conjugation Kit | 9 LBS | 16 × 16 × 16 IN | 胶体金偶联试剂盒,优化蛋白-金标记物偶联物 |
" data-original="http://southernbiotech.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理DCN Dx品牌全系列产品"> 艾美捷科技代理DCN Dx品牌全系列产品

艾美捷科技代理Giotto Biotech品牌。
Giotto Biotech公司是一家专注于核磁共振(NMR)相关技术的意大利生物技术公司。Giotto Biotech Srl是佛罗伦萨大学磁共振中心(CERM)的衍生品或分公司,与佛罗伦萨大学磁共振中心保持着密切的合作关系。Giotto Biotech专注于与核磁共振(NMR)有关的所有技术,致力于为学术和工业研究团体提供高质量的产品和服务。Giotto Biotech公司提供的产品和服务涵盖了多个领域:
(1)生物分子与有机合成:提供生物分子和有机合成相关的产品和服务,满足学术和工业研究的需求。
(2)代谢组学:利用NMR技术进行代谢组学研究,为客户提供代谢产物的定性和定量分析服务。
(3)NMR访问与信息技术:提供NMR仪器的访问权限以及相关的信息技术产品和服务,支持客户的NMR研究。
(4)定制生产服务:拥有大量的蛋白质表达产物,可以通过在大肠杆菌中的表达产生蛋白质。同时,公司还提供定制生产服务,包括重组蛋白质、肽类、有机分子和抗体等同位素标记的定制生产。
Giotto Biotech公司拥有丰富的蛋白质库,包括多种基质金属蛋白酶、S100蛋白质、Fe-S蛋白质等,可以满足客户在蛋白质研究方面的需求。Giotto Biotech注重产品质量和服务质量,通过质谱和NMR光谱等手段保证产品的纯度和质量,产品和服务广泛应用于生物医学、制药、农业和食品等多个领域。在生物医学领域,公司提供的代谢组学服务可以帮助研究人员进行疾病指纹图谱的构建和生物标志物的发现;在制药领域,公司可以利用NMR技术进行药物毒性的预测和药物作用机制的分析;在农业和食品领域,公司可以提供食品成分的分析和质量控制等服务。
<< " data-original="http://southernbiotech.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理Giotto Biotech品牌"> 艾美捷科技代理Giotto Biotech品牌地址:武汉市洪山区光谷大道35号光谷总部国际时代 二期1栋1301
电话:18771149750
传真:18327026838
邮箱:sales@amyjet.com
0.1942